Post Marketing Surveillance for Contac Bien Z in Japan
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Adverse events after having cetrizine hydrochloride [ Time Frame: At baseline ]
Participants will answer a questionnaire which consists of questions on safety of the marketed cetrizine hydrochloride formulation.
Secondary Outcome Measures :
Efficacy of the marketed cetrizine hydrochloride formulation [ Time Frame: At baseline ]
Participants will answer a questionnaire which consists of questions on their satisfaction after taking the marketed cetrizine hydrochloride formulation. The efficacy will be measured on a 4 point scale (1 Efficacious; 2 Somewhat efficacious; 3 Not efficacious; 4 Not known)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
15 Years to 65 Years (Child, Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Participants who purchase the marketed cetrizine hydrochloride formulation from pharmacy stores in Japan.
Male and female participants, between 15-65 years of age, who purchase the marketed cetrizine hydrochloride formulation
Who have ever experienced allergic symptoms by taking this medication or any component of this medication, piperazine derivative (including levocetirizine, hydroxizine)
Those who have been under 15en diagnosed with kidney disease